We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ELOX market cap is 314.34. The company's latest EPS is USD -11.4733 and P/E is 0.00.
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -47.57M | -50.56M | -33.46M | -66.02M | -34.42M |
Net Income | -47.19M | -50.87M | -34.58M | -66.73M | -36.07M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 50.72M | 58.95M | 26.48M | 45.14M | 21.12M |
Total Liabilities | 7.81M | 22.73M | 16.25M | 22.76M | 31.78M |
Total Equity | 42.91M | 36.21M | 10.23M | 22.38M | -10.66M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -31.37M | -39.39M | -28.17M | -35M | -31.85M |
Investing | -317k | -33.52M | 33.79M | 2.06M | -66k |
Financing | 56.18M | 46.8M | -3.44M | 50.79M | 8.81M |
Market Cap | 314.34 |
Price to Earnings Ratio | 0.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 3.14M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 563 |
52 Week Change | -100.00% |
52 Week High | 3.51 |
52 Week Low | 0.000001 |
Spread (Intraday) | 0 (0%) |
Company Name | Eloxx Pharmaceuticals Inc (CE) |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.eloxxpharma.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions